|
RASSF9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10650377749266E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.86255480325326E-12 |
| Normal-vs-Stage3 |
8.13782374819993E-12 |
| Normal-vs-Stage4 |
1.182040E-03 |
| Stage1-vs-Stage2 |
7.101400E-01 |
| Stage1-vs-Stage3 |
8.289800E-01 |
| Stage1-vs-Stage4 |
5.298300E-02 |
| Stage2-vs-Stage3 |
8.082200E-01 |
| Stage2-vs-Stage4 |
1.028770E-01 |
| Stage3-vs-Stage4 |
1.109210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.0622618036632E-12 |
| Normal-vs-AfricanAmerican |
8.88640000473728E-08 |
| Normal-vs-Asian |
1.196910E-04 |
| Caucasian-vs-AfricanAmerican |
3.559800E-02 |
| Caucasian-vs-Asian |
5.426400E-01 |
| AfricanAmerican-vs-Asian |
2.822600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.47484280133403E-12 |
| Normal-vs-Female |
1.15519815935272E-11 |
| Male-vs-Female |
1.005160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.63249999962645E-07 |
| Normal-vs-Extreme_Weight |
3.91831012080956E-12 |
| Normal-vs-Obese |
3.10862446895044E-15 |
| Normal-vs-Extreme_Obese |
3.11039999978391E-07 |
| Normal_Weight-vs-Extreme_Weight |
7.426300E-02 |
| Normal_Weight-vs-Obese |
5.310600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.699400E-01 |
| Extreme_Weight-vs-Obese |
2.741600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.674800E-01 |
| Obese-vs-Extreme_Obese |
4.961000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.08969999970776E-07 |
| Normal-vs-Age(41-60Yrs) |
6.12665473909146E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.31759056390501E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.433800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.854200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.121350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.122200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.229800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.044200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.2058800059076E-12 |
| Normal-VS-Type2 PRCC |
2.78332912273527E-13 |
| Normal-VS-KIRP CIMP |
6.703400E-03 |
| Normal-VS-Unclassified PRCC |
1.6527001989175E-11 |
| Type1 PRCC-VS-Type2 PRCC |
1.368980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.495600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.296100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.494500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.819600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.826400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.95412608106471E-13 |
| Normal-vs-N1 |
2.14380000418402E-08 |
| Normal-vs-N2 |
3.733800E-02 |
| N0-vs-N1 |
1.533820E-02 |
| N0-vs-N2 |
3.531800E-01 |
| N1-vs-N2 |
4.477800E-01 |
|
|
